MiNDERA Corporation Company
MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases. The company is currently focused on a technology solution to extract skin biomarkers in a non-invasive manner.
MiNDERA Dx was founded in 2013 and is based in San Francisco, United States.
MiNDERA Dx was founded in 2013 and is based in San Francisco, United States.
Technology:
Personalized Diagnostics
Industry:
Precision Medicine
Headquarters:
South San Francisco
Founded Date:
2013
Employees Number:
11-50
Funding Status:
undisclosed
Register and Claim Ownership